Baxter reports Q2 growth; Will the device ID program work?;

@FierceMedDev: Medtronic appears to be negotiating with Indian device giant Trivitron Healthcare for a "strategic investment." More | Follow @FierceMedDev

 @MarkHFierce: U.K. Sanofi site draws $7.8M investment for asthma inhaler production. Item | Follow @MarkHFierce

 @DamianFierce: Quest Dx and LabCorp are scaling back expectations after a tepid Q2. More | Follow @DamianFierce

> Should companies be legally allowed in the U.S. to obtain patents on genetic material, and on procedures that use that material for both medical diagnoses and treatments? A federal court will begin hearing arguments on the matter this week, Bloomberg reports. Story

> Baxter ($BAX) expects sales growth to reach 5-6% in its 2012 third quarter, excluding the impact of foreign currency, and earnings per diluted share of $1.12 to $1.14 before any special items. Release

> The FDA's new device ID plan is meant to keep patients safe, but will it work? Article

> The FDA has cleared pSivida's ($PSDV) investigational new drug application to treat posterior uveitis with its injectable sustained-release micro-insert, which means the company will advance to two Phase II trials to treat patients with posterior uveitis, enrolling 300 patients. Release

> Canada's Verisante Technology is gearing up for the commercial launch of new skin cancer diagnostic technology. Release

> Stanford's Henry Miller says the growing regulatory burden in the U.S. will force devicemakers to move their R&D and manufacturing operations overseas. Column

> AorTech, the company that manufactures polymer coatings for St. Jude Medical's ($STJ) Durata leads, is up for sale. Report

> Tornier in The Netherlands has appointed Shawn T. McCormick as its new chief financial officer as of Sept. 4, 2012. McCormick is a veteran medical device executive who previously served various leadership roles at Medtronic, ev3 and Lutonix. Release

Biotech News

 @FierceBiotech: Study: Low-income patients less likely to join cancer‬ trials. Report | Follow @FierceBiotech

 @JohnCFierce: Interesting approach--super high risk; EnVivo grabs ‪Alzheimer‬'s spotlight with promising PhIIb results. News | Follow @JohnCFierce

 @RyanMFierce: Innovation in ‪pharma‬ manufacturing is under-appreciated. Thinking about this as I cover Novartis' woes at Lincoln, NE plant. Hurt Q2 sales.  | Follow @RyanMFierce

> Faded star at Pfizer leads to discounted $68M IPO for Durata. Article

> Infinity restructures drug deal, raises $27.5M as it scrambles to refocus. News

> Multibillion-dollar R&D strategy is paying off for Novartis. More

Pharma News

 @FiercePharma: PDI expects $57M from deal to market 'newly FDA approved drug'. ‪Vivus‬ diet pill Qsymia, maybe? Release | Follow @FiercePharma

> New bill aims to mandate abuse-deterrent painkillers. Report

> Novartis leans on emerging markets, new meds to offset Diovan drop. News

> Plavix tops U.S. sales ranks, but not for long. More

CRO News

> Medpace adds clinical pharma unit for PhI trials. Story

> ScinoPharm will manufacture blockbuster hopeful Qsymia. Article

> Europe moves toward liberalizing clinical trial rules. More

> Study: Low-income patients less likely to join cancer trials. Report

> Indian regulators shutter 12 drug plants over enviro concerns. News

Vaccines News

> Galena stock jumps with NeuVax patent. Report

> Oral vax rides on advanced microparticles. News

> Silk could eliminate 'cold chain' need. Story

> MedImmune to cut 200 jobs, layoffs hit vax R&D. Article

> University of Birmingham explores attitudes toward polio vax in India. More

> HIV-positive patients approved for smallpox vax in an emergency. Item

Pharma Manufacturing News

> Novartis's Q2 sales hit after Excedrin production woes. News

> Sanofi plant adds 40 to produce SkyePharma product. More

> Docs reportedly get smuggled cancer drugs in Pakistan bazaar. Story

> J&J 'decree' upgrades cost 200 jobs in Puerto Rico. Article

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.